Disruption of the cell-cell junction with concomitant changes in the expression of junctional proteins is a hallmark of cancer cell invasion and metastasis. The role of adherent junction proteins has been studied extensively in cancer, but the roles of tight junction (TJ) proteins are less well understood. Claudins are recently identified members of the tetraspanin family of proteins, which are integral to the structure and function of TJs. Recent studies show changes in expression/cellular localization of claudins during tumorigenesis; however, a causal relationship between claudin expression/localization and cancer has not been established. Here, we report an increased expression of claudin-1 in human primary colon carcinoma and metastasis and in cell lines derived from primary and metastatic tumors. We also report frequent nuclear localization of claudin-1 in these samples. Genetic manipulations of claudin-1 expression in colon cancer cell lines induced changes in cellular phenotype, with structural and functional changes in markers of epithelial-mesenchymal transition. Furthermore, we demonstrate that changes in claudin-1 expression have significant effects on growth of xenografted tumors and metastasis in athymic mice. We further provide data suggesting that the regulation of E-cadherin expression and β-catenin/Tcf signaling is a possible mechanism underlying claudin-1–dependent changes.
Punita Dhawan, Amar B. Singh, Natasha G. Deane, YiRan No, Sheng-Ru Shiou, Carl Schmidt, John Neff, M. Kay Washington, R. Daniel Beauchamp
Title and authors | Publication | Year |
---|---|---|
A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
S Gowrikumar, M Primeaux, K Pravoverov, C Wu, BC Szeglin, CE Sauvé, I Thapa, D Bastola, , JJ Smith, AB Singh, P Dhawan |
Cells | 2021 |
Moonlighting Proteins Are Important Players in Cancer Immunology
A Adamo, C Frusteri, MT Pallotta, T Pirali, S Sartoris, S Ugel |
Frontiers in immunology | 2021 |
Colon epithelial cell TGFβ signaling modulates the expression of tight junction proteins and barrier function in mice
PM Smith, YA Choksi, NO Markham, DN Hanna, J Zi, CJ Weaver, JA Hamaamen, KB Lewis, J Yang, Q Liu, I Kaji, AL Means, RD Beauchamp |
AJP Gastrointestinal and Liver Physiology | 2021 |
Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation
B Kumar, R Ahmad, GA Giannico, R Zent, GA Talmon, RC Harris, PE Clark, V Lokeshwar, P Dhawan, AB Singh |
Journal of Experimental & Clinical Cancer Research | 2021 |
Dysregulated expression of claudins in cancer (Review)
J Li |
Oncology Letters | 2021 |
Context-Dependent Roles of Claudins in Tumorigenesis
J Li |
Frontiers in Oncology | 2021 |
Altered expression of junctional proteins as a potential biomarker in oral precancerous and cancerous patients
P Upadhaya, S Giri, D Barhoi, A Bhattacharjee |
Tissue Barriers | 2021 |
The blood–brain and gut–vascular barriers: from the perspective of claudins
AA Scalise, N Kakogiannos, F Zanardi, F Iannelli, M Giannotta |
Tissue Barriers | 2021 |
Constitutive activation of mitogen-activated protein kinase kinase (MEK1) in ileal enterocytes leads to dysplasia and a predisposition to cancer
BL Shneider, N Cortes-Santiago, DA Schady, S Krishnamoorthy, S Thevananther, K Rajapakshe, D Perera, S Huang, C Coarfa |
AJP Gastrointestinal and Liver Physiology | 2021 |
Crosstalk between the oral microbiota, mucosal immunity, and the epithelial barrier regulates oral mucosal disease pathogenesis
D Lin, L Yang, L Wen, H Lu, Q Chen, Z Wang |
Mucosal Immunology | 2021 |
MASTL regulates EGFR signaling to impact pancreatic cancer progression
I Fatima, S Barman, JP Uppada, S Chauhan, S Rauth, S Rachagani, MP Ponnusamy, L Smith, G Talmon, AB Singh, SK Batra, P Dhawan |
Oncogene | 2021 |
Bioactive glass promotes the barrier functional behaviors of keratinocytes and improves the Re-epithelialization in wound healing in diabetic rats
F Tang, J Li, W Xie, Y Mo, L Ouyang, F Zhao, X Fu, X Chen |
Bioactive Materials | 2021 |
Withaferin A mitigates metastatic traits in human oral squamous cell carcinoma caused by aberrant claudin-1 expression
JA Shin, LH Kim, MH Ryu, SY Choi, B Jin, WW Lee, YC Jung, CH Ahn, MH Ahn, KO Hong, N Swarup, K Chawla, SC Kang, SD Hong, SD Cho |
Cell Biology and Toxicology | 2021 |
TGF-β1 increases permeability of ciliated airway epithelia via redistribution of claudin 3 from tight junction into cell nuclei
C Schilpp, R Lochbaum, P Braubach, D Jonigk, M Frick, P Dietl, OH Wittekindt |
Pflügers Archiv - European Journal of Physiology | 2021 |
Extracellular Matrix Biomarkers in Colorectal Cancer
MS Kim, SE Ha, M Wu, H Zogg, CF Ronkon, MY Lee, S Ro |
International journal of molecular sciences | 2021 |
Claudins as biomarkers of differential diagnosis and prognosis of tumors
OP Popova, AV Kuznetsova, SY Bogomazova, AA Ivanov |
Journal of Cancer Research and Clinical Oncology | 2021 |
Effects of 1,2-Dimethylhydrazine on Barrier Properties of Rat Large Intestine and IPEC-J2 Cells
V Bekusova, L Droessler, S Amasheh, AG Markov |
International journal of molecular sciences | 2021 |
Intestinal Barrier, Claudins and Mycotoxins
MJ Kozieł, M Ziaja, AW Piastowska-Ciesielska |
Toxins | 2021 |
STW 5 Herbal Preparation Modulates Wnt3a and Claudin 1 Gene Expression in Zebrafish IBS-like Model.
Piccione M, Facchinello N, Schrenk S, Gasparella M, Pathak S, Ammar RM, Rabini S, Dalla Valle L, Di Liddo R |
Pharmaceuticals (Basel, Switzerland) | 2021 |
Knocking down claudin receptors leads to a decrease in prostate cancer cell migration, cell growth, cell viability and clonogenic cell survival
Liu Q, Shen H, Naguib A, Weiss RM, Martin DT |
2021 | |
Expression of Claudin-1 in laryngeal squamous cell carcinomas (LSCCs) and its significance.
Ouban A |
Histology and histopathology | 2021 |
Claudins: Beyond Tight Junctions in Human IBD and Murine Models.
Čužić S, Antolić M, Ognjenović A, Stupin-Polančec D, Petrinić Grba A, Hrvačić B, Dominis Kramarić M, Musladin S, Požgaj L, Zlatar I, Polančec D, Aralica G, Banić M, Urek M, Mijandrušić Sinčić B, Čubranić A, Glojnarić I, Bosnar M, Eraković Haber V |
Frontiers in pharmacology | 2021 |